New research led by Harvard Medical School investigators at Massachusetts General Hospital, Dana-Farber Cancer Institute, and ...

New program led by HMS faculty at Massachusetts General Hospital aims to bring the first disease-modifying therapies to ...

At the start of each academic year, entering students at Harvard Medical School, Harvard School of Dental Medicine, and many other health professional schools in the United States and abroad receive a ...

Aspiring physician and recent college graduate Minjae (MJ) Eum intends to change circumstances and attitudes about medicine and health care in her home state, Alabama, patient by patient. Many people ...

Applying new analytic methods to nearly 16,000 ancient genomes reveals natural selection has acted on hundreds, not dozens, of genes in West Eurasia over the last 10,000 years. More than half of the ...

The future of federally funded research at Harvard Medical School — supported by taxpayers and done in service to humanity — remains uncertain. Learn more. A new analysis led by researchers at Harvard ...

A new study reveals that pathology AI models for cancer diagnosis perform unequally across demographic groups. The researchers identified three explanations for the bias and developed a tool that ...

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets. He has studied how national ...

New AI tool accurately identifies multiple drivers of disease in cells and predicts therapies that can restore cells to healthy function. The advance moves away from traditional drug discovery ...

Study shows for the first time that lithium plays an essential role in normal brain function and can confer resistance to brain aging and Alzheimer’s disease. Scientists discovered that lithium is ...

A new study in mice describes how the brain rapidly and efficiently increases blood flow to active areas where oxygen and nutrients are needed most. The work shows that the brain relies on a ...

First-in-class medication halts HIV replication by disrupting a critical piece of the viral machinery — the capsid protein shell that protects the vial genome. Twice-a-year injection removes ...